Medtronic ROA 2012-2026 | MDT
Current and historical return on assets (ROA) values for Medtronic (MDT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Medtronic ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-07-31 | $5.23B | $92.29B | 5.67% |
| 2026-04-30 | $4.80B | $91.71B | 5.24% |
| 2026-01-31 | $4.61B | $91.37B | 5.05% |
| 2025-10-31 | $4.76B | $90.99B | 5.24% |
| 2025-07-31 | $4.66B | $90.67B | 5.14% |
| 2025-04-30 | $4.66B | $90.36B | 5.16% |
| 2025-01-31 | $4.26B | $89.94B | 4.74% |
| 2024-10-31 | $4.29B | $90.15B | 4.76% |
| 2024-07-31 | $3.93B | $90.16B | 4.36% |
| 2024-04-30 | $3.68B | $90.42B | 4.07% |
| 2024-01-31 | $4.20B | $90.66B | 4.63% |
| 2023-10-31 | $4.10B | $91.49B | 4.48% |
| 2023-07-31 | $3.62B | $92.28B | 3.92% |
| 2023-04-30 | $3.76B | $92.06B | 4.08% |
| 2023-01-31 | $4.06B | $92.07B | 4.41% |
| 2022-10-31 | $4.32B | $91.49B | 4.72% |
| 2022-07-31 | $5.21B | $91.11B | 5.71% |
| 2022-04-30 | $5.04B | $91.59B | 5.50% |
| 2022-01-31 | $4.91B | $92.11B | 5.33% |
| 2021-10-31 | $4.70B | $93.48B | 5.03% |
| 2021-07-31 | $3.88B | $94.51B | 4.11% |
| 2021-04-30 | $3.61B | $95.04B | 3.79% |
| 2021-01-31 | $2.89B | $94.44B | 3.06% |
| 2020-10-31 | $3.54B | $93.33B | 3.79% |
| 2020-07-31 | $4.41B | $92.12B | 4.79% |
| 2020-04-30 | $4.79B | $91.46B | 5.24% |
| 2020-01-31 | $5.32B | $91.21B | 5.83% |
| 2019-10-31 | $4.67B | $90.19B | 5.18% |
| 2019-07-31 | $4.42B | $89.46B | 4.94% |
| 2019-04-30 | $4.63B | $89.07B | 5.20% |
| 2019-01-31 | $4.92B | $89.50B | 5.50% |
| 2018-10-31 | $2.26B | $91.27B | 2.48% |
| 2018-07-31 | $3.16B | $92.84B | 3.41% |
| 2018-04-30 | $3.10B | $95.48B | 3.25% |
| 2018-01-31 | $2.81B | $97.59B | 2.88% |
| 2017-10-31 | $5.02B | $98.04B | 5.12% |
| 2017-07-31 | $4.12B | $99.02B | 4.16% |
| 2017-04-30 | $4.03B | $98.61B | 4.08% |
| 2017-01-31 | $3.97B | $98.56B | 4.03% |
| 2016-10-31 | $4.24B | $99.84B | 4.25% |
| 2016-07-31 | $3.65B | $101.47B | 3.59% |
| 2016-04-30 | $3.54B | $102.98B | 3.44% |
| 2016-01-31 | $2.43B | $104.74B | 2.32% |
| 2015-10-31 | $2.32B | $92.87B | 2.49% |
| 2015-07-31 | $2.62B | $76.33B | 3.44% |
| 2015-04-30 | $2.68B | $59.56B | 4.49% |
| 2015-01-31 | $3.12B | $42.38B | 7.37% |
| 2014-10-31 | $2.91B | $37.88B | 7.68% |
| 2014-07-31 | $2.98B | $37.30B | 8.00% |
| 2014-04-30 | $3.07B | $36.65B | 8.36% |
| 2014-01-31 | $3.59B | $35.89B | 9.99% |
| 2013-10-31 | $3.81B | $35.32B | 10.79% |
| 2013-07-31 | $3.56B | $34.70B | 10.25% |
| 2013-04-30 | $3.47B | $34.27B | 10.12% |
| 2013-01-31 | $3.49B | $33.75B | 10.34% |
| 2012-10-31 | $3.44B | $32.99B | 10.41% |
| 2012-07-31 | $3.66B | $32.43B | 11.28% |
| 2012-04-30 | $3.62B | $31.89B | 11.34% |
| 2012-01-31 | $3.40B | $31.36B | 10.85% |
| 2011-10-31 | $3.39B | $31.03B | 10.93% |
| 2011-07-31 | $3.09B | $30.42B | 10.15% |
| 2011-04-30 | $3.10B | $29.81B | 10.39% |
| 2011-01-31 | $3.28B | $29.17B | 11.23% |
| 2010-10-31 | $3.18B | $27.81B | 11.44% |
| 2010-07-31 | $3.48B | $26.55B | 13.12% |
| 2010-04-30 | $3.10B | $25.28B | 12.26% |
| 2010-01-31 | $2.25B | $24.15B | 9.30% |
| 2009-10-31 | $2.11B | $23.55B | 8.97% |
| 2009-07-31 | $1.79B | $22.99B | 7.79% |
| 2009-04-30 | $2.07B | $22.78B | 9.09% |
| 2009-01-31 | $2.69B | $22.43B | 11.98% |
| 2008-10-31 | $2.07B | $22.09B | 9.36% |
| 2008-07-31 | $2.19B | $21.73B | 10.06% |
| 2008-04-30 | $2.14B | $20.96B | 10.20% |
| 2008-01-31 | $2.23B | $20.29B | 10.99% |
| 2007-10-31 | $2.86B | $19.83B | 14.44% |
| 2007-07-31 | $2.88B | $19.41B | 14.83% |
| 2007-04-30 | $2.80B | $19.54B | 14.34% |
| 2007-01-31 | $2.73B | $19.58B | 13.94% |
| 2006-10-31 | $2.69B | $19.27B | 13.95% |
| 2006-07-31 | $2.83B | $18.99B | 14.88% |
| 2006-04-30 | $2.55B | $18.17B | 14.02% |
| 2006-01-31 | $2.00B | $17.41B | 11.50% |
| 2005-10-31 | $1.88B | $16.75B | 11.21% |
| 2005-07-31 | $1.60B | $16.10B | 9.91% |
| 2005-04-30 | $1.81B | $15.51B | 11.64% |
| 2005-01-31 | $2.18B | $14.89B | 14.64% |
| 2004-10-31 | $2.10B | $14.32B | 14.66% |
| 2004-07-31 | $2.04B | $13.75B | 14.83% |
| 2004-04-30 | $1.96B | $13.27B | 14.76% |
| 2004-01-31 | $1.88B | $12.84B | 14.61% |
| 2003-10-31 | $1.84B | $12.46B | 14.77% |
| 2003-07-31 | $1.67B | $12.10B | 13.78% |
| 2003-04-30 | $1.60B | $11.74B | 13.63% |
| 2003-01-31 | $1.41B | $11.37B | 12.44% |
| 2002-10-31 | $1.30B | $10.92B | 11.91% |
| 2002-07-31 | $1.07B | $10.49B | 10.16% |
| 2002-04-30 | $0.99B | $9.51B | 10.36% |
| 2002-01-31 | $0.83B | $8.54B | 9.76% |
| 2001-10-31 | $0.82B | $7.64B | 10.77% |
| 2001-07-31 | $1.06B | $6.75B | 15.76% |
| 2001-04-30 | $1.05B | $6.40B | 16.34% |
| 2001-01-31 | $1.22B | $6.07B | 20.08% |
| 2000-10-31 | $1.18B | $5.79B | 20.28% |
| 2000-07-31 | $1.12B | $5.55B | 20.27% |
| 2000-04-30 | $1.09B | $5.32B | 20.45% |
| 2000-01-31 | $0.93B | $5.12B | 18.13% |
| 1999-10-31 | $0.63B | $4.99B | 12.71% |
| 1999-07-31 | $0.49B | $4.66B | 10.59% |
| 1999-04-30 | $0.47B | $4.10B | 11.53% |
| 1999-01-31 | $0.47B | $3.58B | 13.19% |
| 1998-10-31 | $0.51B | $3.02B | 17.01% |
| 1998-07-31 | $0.54B | $2.71B | 19.93% |
| 1998-04-30 | $0.46B | $2.64B | 17.31% |
| 1998-01-31 | $0.44B | $2.55B | 17.38% |
| 1997-10-31 | $0.57B | $2.56B | 22.09% |
| 1997-07-31 | $0.55B | $2.57B | 21.34% |
| 1997-04-30 | $0.53B | $2.59B | 20.49% |
| 1997-01-31 | $0.51B | $2.61B | 19.39% |
| 1996-10-31 | $0.48B | $2.49B | 19.41% |
| 1996-07-31 | $0.46B | $2.34B | 19.58% |
| 1996-04-30 | $0.43B | $2.21B | 19.42% |
| 1996-01-31 | $0.40B | $2.07B | 19.08% |
| 1995-10-31 | $0.36B | $1.94B | 18.49% |
| 1995-07-31 | $0.33B | $1.84B | 17.75% |
| 1995-04-30 | $0.29B | $1.73B | 16.96% |
| 1995-01-31 | $0.27B | $1.65B | 16.53% |
| 1994-10-31 | $0.26B | $1.55B | 16.69% |
| 1994-07-31 | $0.25B | $1.45B | 16.96% |
| 1994-04-30 | $0.23B | $1.35B | 17.27% |
| 1994-01-31 | $0.22B | $1.27B | 17.68% |
| 1993-10-31 | $0.22B | $1.27B | 16.99% |
| 1993-07-31 | $0.22B | $1.28B | 17.16% |
| 1993-04-30 | $0.21B | $1.26B | 16.79% |
| 1993-01-31 | $0.20B | $1.23B | 16.34% |
| 1992-10-31 | $0.19B | $1.18B | 16.23% |
| 1992-07-31 | $0.17B | $1.13B | 15.12% |
| 1992-04-30 | $0.16B | $1.09B | 14.77% |
| 1992-01-31 | $0.16B | $1.06B | 14.78% |
| 1991-10-31 | $0.15B | $1.02B | 14.82% |
| 1991-07-31 | $0.14B | $0.99B | 14.22% |
| 1991-04-30 | $0.13B | $0.96B | 13.97% |
| 1991-01-31 | $0.13B | $0.93B | 13.74% |
| 1990-10-31 | $0.12B | $0.89B | 13.57% |
| 1990-07-31 | $0.12B | $0.84B | 13.86% |
| 1990-04-30 | $0.11B | $0.81B | 13.77% |
| 1990-01-31 | $0.11B | $0.78B | 13.42% |
| 1989-10-31 | $0.10B | $0.76B | 13.49% |
| 1989-07-31 | $0.10B | $0.73B | 13.58% |
| 1989-04-30 | $0.10B | $0.72B | 13.98% |
| 1989-01-31 | $0.10B | $0.69B | 13.86% |
| 1988-10-31 | $0.09B | $0.65B | 14.24% |
| 1988-07-31 | $0.09B | $0.63B | 14.67% |
| 1988-04-30 | $0.09B | $0.60B | 14.61% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $119.983B | $36.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |